Algeria has received its first batch of COVID-19 vaccines under the COVAX initiative, coordinated globally by Gavi, the Vaccine Alliance. According to Gavi, the Vaccine Alliance, the shipment marks the start of a broader immunization campaign intended to cover 20% of the country’s population.
The delivery is part of an international effort to ensure equitable access to vaccines, particularly for low- and middle-income countries. Algeria, like many others, is relying on COVAX to secure doses amid global shortages and supply chain constraints. According to Gavi, the Vaccine Alliance, the vaccines distributed through COVAX are procured through agreements with manufacturers and funded by donor countries and private partners.
For Algerian entrepreneurs and small business owners, the vaccine rollout brings both immediate logistical considerations and longer-term economic implications. Businesses across sectors—from retail and hospitality to manufacturing and services—have faced repeated disruptions due to pandemic-related restrictions. A steady vaccine rollout could support a gradual return to normal operations, particularly in sectors dependent on mobility or large gatherings.
The COVAX program aims to deliver 2 billion doses globally by the end of 2021, with Algeria set to receive enough doses to vaccinate 20% of its population—approximately 9.2 million people based on a 2020 population estimate from the World Bank. The first delivery included doses of the AstraZeneca vaccine, which has been approved for emergency use by the World Health Organization and is suitable for countries with limited ultra-low temperature storage capacity.
Algeria’s participation in COVAX was confirmed during the first quarter of 2021, following months of global negotiations and logistical planning. The government has emphasized the importance of equitable distribution, prioritizing health workers, the elderly, and individuals with chronic conditions. According to Gavi, the Vaccine Alliance, Algeria is among 92 low- and middle-income countries receiving support through the initiative.
For the Algerian diaspora, particularly entrepreneurs and investors with ties to the country, the vaccine rollout may signal a cautious easing of travel and business restrictions in the coming months. However, the timeline remains uncertain, as vaccine deployment depends on supply availability, distribution logistics, and local public health capacity.
Small and medium-sized enterprises (SMEs) in Algeria have been particularly hard hit by the pandemic. A 2020 survey by the Algerian Chamber of Commerce and Industry found that 60% of SMEs reported a drop in revenue of more than 30% since March 2020. While the vaccine rollout offers hope, recovery will depend on consistent access to doses and sustained policy support, including credit facilities and tax relief, which have been unevenly applied.
The role of the Algerian diaspora in supporting local businesses during the crisis has been notable. Many entrepreneurs abroad have redirected investments, provided remittances, or facilitated supply chain connections to help SMEs survive. With vaccines now in the country, diaspora investors may see improved conditions for re-engaging with on-the-ground operations or launching new ventures, especially in sectors like digital services, renewable energy, and agribusiness—areas where Algeria is seeking diversification.
According to Gavi, the Vaccine Alliance, Algeria is expected to receive additional shipments in the coming months as part of the COVAX allocation. The pace of delivery will be closely monitored by both public health authorities and the private sector, as it directly impacts economic reopening timelines.
Key takeaway for entrepreneurs
Algeria’s participation in COVAX provides a pathway to gradual business recovery by supporting workforce health and mobility. SMEs should prepare for phased reopening and consider leveraging diaspora networks to access resources and markets. Vaccine availability may influence investor confidence, particularly in sectors reliant on in-person operations.
💡 Starting a business in Algeria? GlobalStart guides you step by step: procedures, real costs, company forms (SARL, EURL, SPA) and CNRC registration.